Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination










Image Number 19 for United States Patent #5518725.

The invention relates to a vaccine which comprises an antigen and a lymphoid organ modifying agent. Suitable lymphoid organ modifying agents include 1,25-dihydroxy Vitamin D.sub.3, biologically active Vitamin D.sub.3 derivatives which are capable of activating the intracellular Vitamin D.sub.3 receptor, all trans-retinoic acid, retinoic acid derivatives, retinol, retinol derivatives and glucocorticoid. The vaccine composition may further comprise an immune response augmenting agent which enhances T cell lymphokine production. Suitable immune response augmenting agents include dehydroepiandrosterone (DHEA) and DHEA-derivatives. Examples of DHEA derivatives include DHEA-sulfate (DHEA-S), 16-.alpha.-bromo-DHEA, 7-oxo-DHEA, 16-.alpha.-Br-DHEA-S and 7-oxo-DHEA-S. The invention also relates to a method for inducing an antigen-specific mucosal immune response in a vertebrate animal which comprises administering a vaccine which comprises an antigen and a lymphoid organ modifying agent with or without an immune response augmenting agent to a site which drains into a peripheral lymphoid compartment.








 
 
  Recently Added Patents
Down-drawable, chemically strengthened glass for cover plate
Polishing composition
Process for preventing polymerization of cracked volatile products during pyrolysis and gasification
Anthranilic diamide compositions for propagle coating
Multistable electromagnetic actuators
Flat panel crystal display employing simultaneous charging of main and subsidiary pixel electrodes
Integrating multimedia capabilities with circuit-switched calls
  Randomly Featured Patents
Solder tray
Tight sands gas well production enhancement system
Package for sealing an integrated circuit die
Compound marked with tritium, its preparation and its use in particular in the determination of the affinity of retinoids for their nuclear receptors and their cytosolic binding protein
Energy recovery snubber
Prover self testing and validation apparatus
Balanced rolling rotor motor compressor
CMOS input level shifting circuit with temperature-compensating n-channel field effect transistor structure
Semiconductor device improved in light shielding property and light shielding package
Calcium fortified acid beverages